Author:
Recknor Chris,Czerwinski Edward,Bone Henry G.,Bonnick Sydney L.,Binkley Neil,Palacios Santiago,Moffett Alfred,Siddhanti Suresh,Ferreira Irene,Ghelani Prayashi,Wagman Rachel B.,Hall Jesse W.,Bolognese Michael A.,Benhamou Claude-Laurent
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynaecology
Reference35 articles.
1. Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy.;JAMA,2001
2. . Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.;Black;Lancet,1996
3. . The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.;Black;N Engl J Med,2003
4. . Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.;Cummings;JAMA,1998
5. Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.;Fogelman;J Clin Endocrinol Metab,2000
Cited by
122 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献